Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma

被引:0
|
作者
Gebhardt, Christoffer
Keller, Laura
Heidrich, Isabel
Koett, Julian
Geidel, Glenn
Abbott, Charles
Boyle, Sean Michael
Pugh, Jason
Chen, Richard
Simon, Ronald
Schneider, Stefan W.
Pantel, Klaus
机构
[1] Univ Med Ctr Hamburg Eppendorf UKE, Skin Canc Ctr, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf UKE, Inst Tumor Biol, Hamburg, Germany
[3] Personalis Inc, Menlo Pk, CA USA
[4] Univ Med Ctr Hamburg Eppendorf UKE, Inst Pathol, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf UKE, Dept Dermatol, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9562
引用
收藏
页数:1
相关论文
共 50 条
  • [41] IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma
    Carter, Jason A.
    Gilbo, Philip
    Atwal, Gurinder S.
    NATURE MEDICINE, 2019, 25 (12) : 1833 - +
  • [42] Association of circulating tumor cells (CTCs) with immune checkpoint inhibitor (ICI) responses in metastatic renal cell carcinoma (mRCC)
    Zhang, T.
    Poellmann, M.
    Park, S-J.
    Bu, J.
    Zhao, R.
    Zhou, Q.
    Agarwal, A.
    Parks, J.
    Reyes-Martinez, M.
    Armstrong, A. J.
    George, D. J.
    Wang, A. Z.
    Hong, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1221 - S1221
  • [43] Neutrophil lymphocyte ratio (NLR) as a predictor of outcomes with immune checkpoint inhibitor (ICI) therapy in genitourinary cancer and melanoma.
    Jeyakumar, Ghayathri
    Bumma, Naresh
    Kim, SeongHo
    Landry, Craig
    Weise, Amy
    Flaherty, Lawrence E.
    Heath, Elisabeth I.
    Silski, Cynthia
    Zechar, Erich
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [44] INCIDENCE OF THROMBOEMBOLISM (TE) IN PATIENTS WITH MELANOMA RECEIVING IMMUNE CHECKPOINT INHIBITOR (ICI) THERAPY AND ITS ADVERSE IMPACT ON SURVIVAL
    Sussman, Tamara
    Roopkumar, Joanna
    Li, Hong
    McCrae, Keith
    Funchain, Pauline
    Khorana, Alok
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A390 - A391
  • [45] Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carcinoma
    Tai, Warren
    Doolittle, Gary C.
    Shah, Zubair
    Atkinson, James B.
    Russell, Elaine
    Genton, Randall E.
    Moslehi, Javid J.
    Porter, Charles B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (12): : 1860 - 1864
  • [46] Salvage immune checkpoint inhibitor (ICI) plus tyrosine kinase inhibitor (TKI) combination therapy for metastatic renal cell carcinoma (mRCC).
    Parikh, Anish B.
    Psutka, Sarah P.
    Yang, Yuanquan
    Collier, Katharine
    Miah, Abdul
    Li, Mingjia
    Mori-Vogt, Sherry
    Hinkley, Megan
    Orcutt, Delaney
    Trott, Elliott
    Gross, Evan
    Hussey, Duncan
    Kramer, Joel
    Oliva, Kaylee
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Clinton, Steven K.
    Yin, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Prediction of response and toxicity to immune checkpoint inhibitor therapies (ICI) in melanoma using deep neural networks machine learning
    Dawood, Zarmeena
    Coudray, Nicolas
    Kim, Randie H.
    Nomikou, Sofia
    Moran, Una
    Weber, Jeffrey S.
    Pavlick, Anna C.
    Wilson, Melissa
    Tsirigos, Aristotelis
    Osman, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Circulating immune cell biomarkers predict response to immune checkpoint inhibitor therapy in metastatic breast cancer
    Bitar, Jin Sun
    Egelston, Colt
    Yost, Susan
    Hou, Wanqiu
    Simran, Padam
    Frankel, Paul
    Sedrak, Mina
    Portnow, Jana
    Mortimer, Joanne
    Yeon, Christina
    Hurria, Arti
    Tang, Aileen
    Martinez, Norma
    Lee, Peter
    Yuan, Yuan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [49] Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
    Yu, Yunfang
    Lin, Dagui
    Li, Anlin
    Chen, Yongjian
    Ou, Qiyun
    Hu, Hai
    Yao, Herui
    JAMA NETWORK OPEN, 2020, 3 (06)
  • [50] Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
    Sussman, Tamara A.
    Li, Hong
    Hobbs, Brian
    Funchain, Pauline
    McCrae, Keith R.
    Khorana, Alok A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (01)